IssuerAnnouncementDetailsV2Portlet

Actions

Jamjoom Pharmaceuticals Factory Co. Announces the Results of the Extraordinary General Assembly Meeting, ( First Meeting )

4015
JAMJOOM PHARMA
0.44 %
1445/09/03     13/03/2024 08:14:15

Element ListExplanation
Introduction The Board of Directors of Jamjoom Pharmaceuticals Factory Company (the “Company”) is pleased to announce the results of the Extraordinary General (First Meeting) Assembly held on Tuesday 2/09/1445H corresponding to 12/03/2024G after the quorum for the validity of the meeting was completed.
City and Location of the General Assembly's Meeting Company’s headquarters in Jeddah, via modern technology means.
Date of the General Assembly's Meeting 2024-03-12 Corresponding to 1445-09-02
Time of the General Assembly’s Meeting 22:00
Percentage of Attending Shareholders 77.31%
Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees The meeting was attended by the following Board Members:

1- Mr. Mahmoud Yousuf Jamjoom (Chairman)

2- Mr. Ahmed Yousuf Jamjoom (Vice Chairman)

3- Mr. Mohammed Yousuf Jamjoom (Member)

4- Mrs. Alaa Yousuf Jamjoom( Member)

5- Mr.Georges P. Schorderet (Member)

The following were unable to attend this meeting:

1- Mr. Yousuf Mohammed Salah Jamjoom (Member)

2- Mr. Faris Ibrahim Abdullah Al Ghannam (Member)

3- Mr.Noor Ahmed Kather Pasha Sheriff (Member)

4- Mr. Michel Marcel Jean-Marie Le Bars (Member)

Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf The following committee chairpersons attended the meeting:

Mr. Georges P. Schorderet (Chairman of the Nomination and Remuneration Committee and Chairman of the Executive Committee).

Voting Results on the Items of the General Assembly's Meeting Agenda's Please Check the attached document
Additional Information The Board of Directors of Jamjoom Pharmaceuticals Factory Company would like to thank the respected shareholders for their participation and attendance of the Extraordinary General Assembly Meeting (First Meeting).

For any inquiries, please directly contact the Investor Relations Department through:

Email:

IR@jamjoompharma.com

Attached Documents  

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.

Company Performance

JAMJOOM PHARMA
Add To Watchlist
In your Watchlist
Add To Watchlist
Key Parameters
Last Price 136.8
Net Change 0.6 (+0.44%)
Value Traded (Sar) 19,814,265.2
Volume Traded 144,605
See The Company Profile

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist